3 Biotech Stocks Poised For Massive Future Growth

The biotech sector has received a lot of attention and hype lately because of the COVID-19 pandemic. The outbreak has highlighted the importance of science in advancing the course of humanity. Investors have been taking notice and are making investment choices. There has been a lot of activity in the biotech sector, most especially as the companies in this sector are directly involved in the race to finding a coronavirus cure. Healthcare stocks have soared as investors bet on a coronavirus vaccine.

Boitech Sector Is Amongst The Best Performers

The sector has been one of the best performers of the U.S stock market, outperforming the broader market, and more than doubling its percentage points on YTD return on equity. This may be why some analysts refer to this turbulent time as the “golden period of biotechnology” – a period when scientific breakthroughs are opening up vistas of possibilities on how we understand, prevent and treat diseases This implies that the companies which would be most profitable would be those that have impacted our health the most.

BioNTech And Others

The current noise going on in the biotech sector makes it is difficult to decipher which stocks have value for investors in the long term. It has been exacerbated by the fact that the sector tends to be one of the most volatile sectors in the market this year. Stocks in the sector have witnessed one of the most impressive rallies since market lows in March, and consequently massive sell-offs after investors were able to weigh the news. Stocks such as Gilead (Nasdaq:GILD), and Sorrento Therapeutics (Nasdaq:SRNE) have reached yearly highs after hyping results of their efforts towards producing a coronavirus treatment.

The market has reacted in different ways to the vaccine news, with each information having implications for not only bullish or bearish movements, but also long and short term holds. Based on the news and market sentiment, investors are rewarding or punishing companies working towards COVID treatments.

1 2 3 4
View single page >> |

Nick Bellini


Nick Bellini is a full-time ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.